D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Chemistry D-index 53 Citations 9,968 161 World Ranking 7512 National Ranking 92

Overview

What is he best known for?

The fields of study he is best known for:

  • Enzyme
  • Organic chemistry
  • Cancer

Subhash Padhye focuses on Stereochemistry, Cancer cell, Cancer research, Pharmacology and Semicarbazone. His Stereochemistry research integrates issues from Antibacterial agent, Medicinal chemistry, Ligand, Crystal structure and Copper. The study incorporates disciplines such as Mevalonic acid, Biochemistry, Gene knockdown and Cytotoxicity in addition to Cancer cell.

He combines subjects such as Immunology and Cancer, Cancer stem cell, Pancreatic cancer with his study of Cancer research. His Pharmacology study combines topics in areas such as Carcinogenesis, Cell cycle and Signal transduction. Subhash Padhye has included themes like Metal, Transition metal and Nickel in his Semicarbazone study.

His most cited work include:

  • Thiosemicarbazone complexes of copper(II): structural and biological studies (703 citations)
  • Transition metal complexes of semicarbazones and thiosemicarbazones (663 citations)
  • Structural and physical correlations in the biological properties of transition metal heterocyclic thiosemicarbazone and S -alkyldithiocarbazate complexes (392 citations)

What are the main themes of his work throughout his whole career to date?

Subhash Padhye spends much of his time researching Stereochemistry, Cancer research, Copper, Biochemistry and Crystal structure. A large part of his Stereochemistry studies is devoted to Semicarbazone. The Cancer research study combines topics in areas such as Cancer, Cancer stem cell, Pancreatic cancer, CD44 and Cell growth.

His work carried out in the field of Cancer brings together such families of science as Curcumin, Pharmacology and Apoptosis. His Copper research is multidisciplinary, relying on both Pyridine, Redox, Metal and Polymer chemistry. His research in Biochemistry intersects with topics in Breast cancer and Plumbagin.

He most often published in these fields:

  • Stereochemistry (28.97%)
  • Cancer research (22.22%)
  • Copper (19.44%)

What were the highlights of his more recent work (between 2013-2021)?

  • Cancer research (22.22%)
  • Cancer (14.68%)
  • Pharmacology (14.68%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Cancer research, Cancer, Pharmacology, Biochemistry and Curcumin. His studies deal with areas such as CD44, Cell growth, Stem cell, Stem cell marker and Cancer cell as well as Cancer research. Subhash Padhye has researched Pharmacology in several fields, including Polyphenol and Solubility.

His Biochemistry research is multidisciplinary, incorporating elements of Lawsone, Breast cancer, Stereochemistry and Mannich base. His Curcumin study combines topics from a wide range of disciplines, such as Creatinine, In vitro, Nephrotoxicity and In vivo. Subhash Padhye combines subjects such as Cancer stem cell and GTPase with his study of Pancreatic cancer.

Between 2013 and 2021, his most popular works were:

  • DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway (103 citations)
  • PAMAM dendrimers as promising nanocarriers for RNAi therapeutics (101 citations)
  • Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 overexpressing pancreatic cancer cells. (83 citations)

In his most recent research, the most cited papers focused on:

  • Enzyme
  • Organic chemistry
  • Cancer

Subhash Padhye mainly focuses on Curcumin, Pharmacology, Pancreatic cancer, Biochemistry and Cancer research. His Curcumin research incorporates elements of Combinatorial chemistry, Zeta potential and Pancreas. His biological study spans a wide range of topics, including Systemic administration, In vivo and PTEN.

His Pancreatic cancer research is under the purview of Cancer. The various areas that he examines in his Biochemistry study include Stereochemistry, Alkyl and Mannich base. His studies deal with areas such as Dendrimer, CD44 and Nanocarriers as well as Cancer research.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Transition metal complexes of semicarbazones and thiosemicarbazones

Subhash Padhyé;George B. Kauffman.
Coordination Chemistry Reviews (1985)

1049 Citations

Thiosemicarbazone complexes of copper(II): structural and biological studies

Douglas X. West;Anthony E. Liberta;Subhash B. Padhye;Rajeev C. Chikate.
Coordination Chemistry Reviews (1993)

978 Citations

Structural and physical correlations in the biological properties of transition metal heterocyclic thiosemicarbazone and S -alkyldithiocarbazate complexes

Douglas X. West;Subhash B. Padhye;Pramila B. Sonawane.
(1991)

602 Citations

Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF.

Shadan Ali;Aamir Ahmad;Sanjeev Banerjee;Subhash Padhye.
Cancer Research (2010)

550 Citations

Novel Schiff base copper complexes of quinoline-2 carboxaldehyde as proteasome inhibitors in human prostate cancer cells.

Shreelekha Adsule;Vivek Barve;Di Chen;Fakhara Ahmed.
Journal of Medicinal Chemistry (2006)

365 Citations

Curcumin Analogue CDF Inhibits Pancreatic Tumor Growth by Switching on Suppressor microRNAs and Attenuating EZH2 Expression

Bin Bao;Shadan Ali;Sanjeev Banerjee;Zhiwei Wang.
Cancer Research (2012)

295 Citations

From here to eternity - the secret of Pharaohs: Therapeutic potential of black cumin seeds and beyond.

Subhash Padhye;Sanjeev Banerjee;Aamir Ahmad;Ramzi Mohammad.
Cancer therapy (2008)

285 Citations

Antitumor Activity of Gemcitabine and Oxaliplatin Is Augmented by Thymoquinone in Pancreatic Cancer

Sanjeev Banerjee;Ahmed O. Kaseb;Zhiwei Wang;Deujan Kong.
Cancer Research (2009)

279 Citations

Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer

Bin Bao;Shadan Ali;Dejuan Kong;Sanila H. Sarkar.
PLOS ONE (2011)

271 Citations

Perspectives on medicinal properties of plumbagin and its analogs

Subhash Padhye;Prasad Dandawate;Mujahid Yusufi;Aamir Ahmad.
Medicinal Research Reviews (2012)

246 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Subhash Padhye

Fazlul H. Sarkar

Fazlul H. Sarkar

Wayne State University

Publications: 93

Ray J. Butcher

Ray J. Butcher

Howard University

Publications: 62

Yiwei Li

Yiwei Li

Wayne State University

Publications: 43

Douglas X. West

Douglas X. West

University of Washington

Publications: 40

George Psomas

George Psomas

Aristotle University of Thessaloniki

Publications: 39

Alfonso Castiñeiras

Alfonso Castiñeiras

University of Santiago de Compostela

Publications: 37

Heloisa Beraldo

Heloisa Beraldo

Universidade Federal de Minas Gerais

Publications: 35

Karuppannan Natarajan

Karuppannan Natarajan

Bharathiar University

Publications: 31

Paul V. Bernhardt

Paul V. Bernhardt

University of Queensland

Publications: 27

Sanjeev Banerjee

Sanjeev Banerjee

Wayne State University

Publications: 27

Hoong-Kun Fun

Hoong-Kun Fun

Universiti Sains Malaysia

Publications: 27

Amirhossein Sahebkar

Amirhossein Sahebkar

Mashhad University of Medical Sciences

Publications: 25

Philip A. Philip

Philip A. Philip

Wayne State University

Publications: 20

Nattamai Bhuvanesh

Nattamai Bhuvanesh

Texas A&M University

Publications: 20

Gautam Sethi

Gautam Sethi

National University of Singapore

Publications: 19

Vladimir B. Arion

Vladimir B. Arion

University of Vienna

Publications: 19

Something went wrong. Please try again later.